Qiagen (NYSE:QGEN) Releases FY25 Earnings Guidance

Qiagen (NYSE:QGEN) updated its FY25 earnings guidance on Monday. The company provided EPS guidance of ~$2.35 for the period, compared to the consensus EPS estimate of $2.27. Qiagen also updated its FY 2025 guidance to 2.350- EPS.

Analyst Ratings Changes

A number of brokerages have issued reports on QGEN. Robert W. Baird lowered Qiagen from an “outperform” rating to a “neutral” rating and cut their target price for the company from $52.00 to $42.00 in a research report on Wednesday, February 19th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $52.50 price target (up from $40.83) on shares of Qiagen in a report on Tuesday, December 10th. Redburn Atlantic lowered shares of Qiagen from a “buy” rating to a “neutral” rating in a report on Friday. UBS Group cut their target price on shares of Qiagen from $50.00 to $48.00 and set a “neutral” rating on the stock in a research note on Friday, February 7th. Finally, Baird R W downgraded Qiagen from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 19th. Eight research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $47.71.

Qiagen Price Performance

Shares of NYSE QGEN opened at $38.24 on Monday. The company has a debt-to-equity ratio of 0.38, a current ratio of 3.61 and a quick ratio of 3.09. The firm has a market capitalization of $8.50 billion, a PE ratio of 106.48, a P/E/G ratio of 2.39 and a beta of 0.62. Qiagen has a 1-year low of $37.63 and a 1-year high of $49.30. The business’s fifty day moving average price is $40.27 and its two-hundred day moving average price is $41.94.

Qiagen (NYSE:QGEN) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.60 by $0.01. Qiagen had a net margin of 4.23% and a return on equity of 13.92%. On average, research analysts expect that Qiagen will post 2.26 EPS for the current year.

About Qiagen

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.